Positron Emission Tomography
DOI: 10.1007/1-84628-007-9_9
|View full text |Cite
|
Sign up to set email alerts
|

Radiohalogens for PET Imaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 94 publications
0
4
0
Order By: Relevance
“…The ubiquity of SV2A in the human brain, however, offers a unique opportunity to peek into the very mechanisms of neurotransmission and improve the understanding, diagnosis, and treatment of epilepsy and other neurological conditions using PET technology. PET has indeed become a cornerstone tool for (pre)­clinical research and routine diagnosis over the past decades; with its convenient 110 min half-life, almost exclusive β + decay, and the significant representation of fluorine in pharmacologically active molecules, fluorine-18, in its no-carrier-added, nucleophilic ([ 18 F]­F – ) form, is one of the most practical nuclides currently in use for clinical PET imaging …”
Section: Introductionmentioning
confidence: 99%
“…The ubiquity of SV2A in the human brain, however, offers a unique opportunity to peek into the very mechanisms of neurotransmission and improve the understanding, diagnosis, and treatment of epilepsy and other neurological conditions using PET technology. PET has indeed become a cornerstone tool for (pre)­clinical research and routine diagnosis over the past decades; with its convenient 110 min half-life, almost exclusive β + decay, and the significant representation of fluorine in pharmacologically active molecules, fluorine-18, in its no-carrier-added, nucleophilic ([ 18 F]­F – ) form, is one of the most practical nuclides currently in use for clinical PET imaging …”
Section: Introductionmentioning
confidence: 99%
“…Radio-halogens are prevalent species in nuclear medicine due to their wide field of applications in molecular imaging and radiotherapy. [1][2][3][4][5][6] Thus, covalent bond formation between radiohalogens and relevant molecular substrates is a major topic in radiochemistry generally, achieved through transfer of standard halogenation reactions to radio-halogenation reactions. Several challenges arise when it comes to performing halogenation in a radiosynthetic context, such as limited chemical sources, extreme dilution of the radio-isotope, large excess of substrate and reagents, radiation protection and isotope half-lives (Scheme 1).…”
Section: Introductionmentioning
confidence: 99%
“…Radiohalogens with a short half-life have been used as radioisotopes for radiopharmaceuticals. 2 For instance, fluorine-18 and iodine-123, as positron and single-photon emitters, respectively, allow for external visualization, thereby proving indispensable for diagnostic applications. In contrast, astatine-211, iodine-131, and bromine-77, which are alpha, beta, and Auger electron emitters, respectively, tend to damage surrounding cells, but can potentially be utilized for therapeutic purposes.…”
Section: Introductionmentioning
confidence: 99%